Skip to main navigation Skip to search Skip to main content

Cancer risk after use of recombinant bone morphogenetic protein-2 for spinal arthrodesis

Eugene J. Carragee, Gilbert Chu, Rajat Rohatgi, Eric L. Hurwitz, Bradley K. Weiner, S. Tim Yoon, Garet Comer, Branko Kopjar

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Cancer risk after use of recombinant bone morphogenetic protein-2 for spinal arthrodesis'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science